Analysts’ Viewpoint on Water for Injection Market Scenario
Water for injection is widely used as raw material, ingredient, and solvent in processing, formulation, and manufacture of pharmaceutical products, active pharmaceutical ingredients (APIs), and intermediates. Sterile water used in the manufacture of pharmaceutical products, whether for washing equipment, rinsing containers, or as analytical reagent, must meet quality standards established by the United States Pharmacopeia (USP), Pharmacopeia Europa, and others (EP). Demand for water for injection is expected to rise during the forecast period in tandem with the expansion of biopharmaceutical and generic injectable industries. Majority of drugs used to treat cancer, cardiovascular diseases, and diabetes are available in injectable form. New drug formulations, rise in prevalence of cancer and cardiovascular diseases, and growth in access to healthcare facilities in emerging economies are likely to drive the market during the forecast period. Pharmaceutical bacteriostatic water production, storage, and distribution systems must be designed, installed, commissioned, and maintained to ensure consistent production of high-quality sterile water.
Water for injection is an important component in several pharmaceutical and life sciences operations. Sterile water for injection USP is a colorless, odorless liquid that is clear. Controlling bacteriostatic water quality during manufacturing, storage, and distribution processes, including microbiological and chemical quality, is a major concern. Water for injection is sterile, hypotonic, and non-pyrogenic, with no bacteriostatic or antimicrobial agents. It is used as a diluent or solvent suitable for intravascular injection. Water for injection is a form of sterile water used to deliver medications or drugs to patients intravenously. Besides making solutions, it is also used as a cleaning agent.
Request a sample to get extensive insights into the Water for Injection Market
Demand for medicines such as vaccines, proteins, antibodies, plasma, enzymes, biologics, and peptides is rising. The biopharmaceuticals market has witnessed strong growth in the past few years, and the trend is expected to continue during the forecast period. The market is anticipated to grow at a high CAGR, nearly twice as fast as the market for conventional pharmaceuticals, in the near future. The biopharmaceutical industry is driven by significant unmet medical needs in the treatment of chronic illnesses, patent expiration of branded biologic drugs that have opened the door for biosimilars, and the prolific production of clinically effective drugs.
Development and expansion of manufacturing facilities suitable for generic formulations is expected to garner more attention from leading companies during the forecast period. This is likely to result in an increase in production of specialty generic injectable products. Demand for sterile water for injection is anticipated to rise due to the growth of biopharmaceutical and generic injectable industries, as bacteriostatic water for injection is an essential component of these industries.
Majority of medications used to treat diabetes, cardiovascular diseases, and cancer are in the injectable dosage form. New drug formulation, increase in demand for cancer treatment, and rise in access to healthcare facilities in emerging economies are the key factors likely to propel the market during the forecast period. Cardiovascular diseases (CVDs) are disorders of the heart and blood vessels. Changing lifestyles and rapidly rising obesity rates are the major contributors to the increase in the number of people suffering from CVDs. According to the WHO, CVDs are the leading cause of death globally, accounting for an estimated 17.9 million deaths each year. Water for injection market manufacturers are making use of these findings to capitalize on incremental opportunities.
Request a custom report on Water for Injection Market
The formulate parenteral drugs segment is projected to dominate the global market, with 60% share by 2031. Development of generic parenteral formulations is a more rapid process compared to branded ones, as these products are exempt from the requirement to conduct clinical trials and toxicity studies. Large numbers of players are entering the global generic injectable market with cost-effective alternatives to branded products. This is leading to the development of parenteral formulations. Need for bacteriostatic water for injection is expected to rise in sync with the growth of biopharmaceutical and generic injectable industries during the forecast period.
Demand for biopharmaceuticals such as vaccines, proteins, antibodies, plasma, enzymes, biologics, and peptides is increasing for the treatment of chronic diseases such as cancer, neurological diseases, and chronic kidney diseases in North America. Thus, the water for injection market demand is growing in the region due to the rise in development of plasma fractionation and specialty enzymes. Key players are making strategic investments in North America. This is likely to boost the water for injection market size in the region during the forecast period. The water for injection market in North America is also anticipated to be driven by well-established healthcare infrastructure, increase in production of distilled water, and high healthcare spending in the region.
The global water for injection market is fragmented, with the presence of a large number of prominent players. Most of the companies are investing significantly in the expansion of product portfolios and mergers & acquisitions. Merck KGaA, Baxter International, Inc., Johnson & Jonson Services, Inc., Abbott, Thermo Fisher Scientific, Pfizer, Inc., Sun Pharmaceutical Ltd., Serum Institute of India, and Novartis are the prominent players operating in the global water for injection market.
Each of these players has been profiled in the water for injection market report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments.
|
Attribute |
Detail |
|
Market Size Value in 2021 |
US$ 21.5 Bn |
|
Market Forecast Value in 2031 |
More than US$ 53.8 Bn |
|
Growth Rate (CAGR) |
9.5% |
|
Forecast Period |
2022–2031 |
|
Historical Data Available for |
2017–2020 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The global water for injection market was valued at US$ 21.5 Bn in 2021
The global water for injection market is projected to reach more than US$ 53.8 Bn by 2031
The global water for injection market is anticipated to grow at a CAGR of 9.5% from 2022 to 2031
Rise in prevalence of several diseases such as cardiovascular diseases and cancer is expected to drive the global market
The formulate parenteral drugs segment held over 60% share of the global water for injection market in 2021
North America is expected to account for the major share of the global water for injection market during the forecast period
Merck KGaA, Baxter International, Inc., Johnson & Jonson Services, Inc., Abbott, Thermo Fisher Scientific, Inc., Pfizer, Inc., Sun Pharmaceutical Ltd., Serum Institute of India, and Novartis
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Water For Injection Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Water For Injection Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. List of Major Manufacturers of Water for Injection
5.1.1. Market Share Analysis (Approx. Value)
5.1.2. Product Analysis- Packaging, Size, and Price
5.1.3. Pricing Model Analysis
5.2. Opportunity Analysis of the U.S. Market
5.2.1. Supplier Point of View
5.2.2. End-user Point of View
5.3. Key Industry Development
5.4. List of Major End-user
5.5. End-user Purchase Requirement (Best Effort Basis)
6. Global Water For Injection Market Analysis and Forecast, by Application
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Application, 2017–2031
6.3.1. Solvent
6.3.1.1. Cell Culture Media
6.3.1.2. Laboratory Reagents
6.3.1.3. Synthesis of Drugs
6.3.1.4. Others
6.3.2. Cleaning Agents
6.3.2.1. Rinsing Vessels
6.3.2.2. Cleaning Equipment
6.3.2.3. Cleaning Primary Packing
6.3.2.4. Materials
6.3.3. Formulate Parenteral Drugs
6.4. Market Attractiveness Analysis, by Application
7. Global Water For Injection Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017–2031
7.3.1. Pharmaceutical and Biotechnology companies
7.3.2. Research Institutes
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Water For Injection Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Water For Injection Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Application, 2017–2031
9.2.1. Solvent
9.2.1.1. Cell Culture Media
9.2.1.2. Laboratory Reagents
9.2.1.3. Synthesis of Drugs
9.2.1.4. Others
9.2.2. Cleaning Agents
9.2.2.1. Rinsing Vessels
9.2.2.2. Cleaning Equipment
9.2.2.3. Cleaning Primary Packing
9.2.2.4. Materials
9.2.3. Formulate Parenteral Drugs
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Pharmaceutical and Biotechnology companies
9.3.2. Research Institutes
9.3.3. Others
9.4. Market Value Forecast, by Country, 2017–2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Application
9.5.2. By End-user
9.5.3. By Country
10. Europe Water For Injection Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Application, 2017–2031
10.2.1. Solvent
10.2.1.1. Cell Culture Media
10.2.1.2. Laboratory Reagents
10.2.1.3. Synthesis of Drugs
10.2.1.4. Others
10.2.2. Cleaning Agents
10.2.2.1. Rinsing Vessels
10.2.2.2. Cleaning Equipment
10.2.2.3. Cleaning Primary Packing
10.2.2.4. Materials
10.2.3. Formulate Parenteral Drugs
10.3. Market Value Forecast, by End-user, 2017–2031
10.3.1. Pharmaceutical and Biotechnology companies
10.3.2. Research Institutes
10.3.3. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017–2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Application
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Water For Injection Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Application, 2017–2031
11.2.1. Solvent
11.2.1.1. Cell Culture Media
11.2.1.2. Laboratory Reagents
11.2.1.3. Synthesis of Drugs
11.2.1.4. Others
11.2.2. Cleaning Agents
11.2.2.1. Rinsing Vessels
11.2.2.2. Cleaning Equipment
11.2.2.3. Cleaning Primary Packing
11.2.2.4. Materials
11.2.3. Formulate Parenteral Drugs
11.3. Market Value Forecast, by End-user, 2017–2031
11.3.1. Pharmaceutical and Biotechnology companies
11.3.2. Research Institutes
11.3.3. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017–2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Application
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Water For Injection Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Application, 2017–2031
12.2.1. Solvent
12.2.1.1. Cell Culture Media
12.2.1.2. Laboratory Reagents
12.2.1.3. Synthesis of Drugs
12.2.1.4. Others
12.2.2. Cleaning Agents
12.2.2.1. Rinsing Vessels
12.2.2.2. Cleaning Equipment
12.2.2.3. Cleaning Primary Packing
12.2.2.4. Materials
12.2.3. Formulate Parenteral Drugs
12.3. Market Value Forecast, by End-user, 2017–2031
12.3.1. Pharmaceutical and Biotechnology companies
12.3.2. Research Institutes
12.3.3. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Application
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Water For Injection Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Application, 2017–2031
13.2.1. Solvent
13.2.1.1. Cell Culture Media
13.2.1.2. Laboratory Reagents
13.2.1.3. Synthesis of Drugs
13.2.1.4. Others
13.2.2. Cleaning Agents
13.2.2.1. Rinsing Vessels
13.2.2.2. Cleaning Equipment
13.2.2.3. Cleaning Primary Packing
13.2.2.4. Materials
13.2.3. Formulate Parenteral Drugs
13.3. Market Value Forecast, by End-user, 2017–2031
13.3.1. Pharmaceutical and Biotechnology companies
13.3.2. Research Institutes
13.3.3. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017–2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Application
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company, 2021
14.3. Company Profiles
14.3.1. Merck KGaA
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Strategic Overview
14.3.2. Novartis
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Strategic Overview
14.3.3. Johnson & Jonson Services, Inc.
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Strategic Overview
14.3.4. Abbott
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Strategic Overview
14.3.5. Thermo Fisher Scientific, Inc.
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Strategic Overview
14.3.6. Pfizer, Inc.
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Strategic Overview
14.3.7. Sun Pharmaceutical Ltd.
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Strategic Overview
14.3.8. Baxter International
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Strategic Overview
14.3.9. Serum Institute of India
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Strategic Overview
List of Tables
Table 01: Global Water for Injection Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 02: Global Water for Injection Market Value (US$ Mn) Forecast, by Solvent, 2017–2031
Table 03: Global Water for Injection Market Value (US$ Mn) Forecast, by Cleaning Agents, 2017–2031
Table 04: Global Water for Injection Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 05: Global Water for Injection Market Value Forecast, by Region, 2017–2031
Table 06: North America Water for Injection Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 07: North America Water for Injection Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 08: North America Water for Injection Market Value (US$ Mn) Forecast, by Solvent, 2017–2031
Table 09: North America Water for Injection Market Value (US$ Mn) Forecast, by Cleaning Agents, 2017–2031
Table 10: North America Water for Injection Market Value (US$ Mn) Forecast, by End-use, 2017–2031
Table 11: Europe Water for Injection Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 12: Europe Water for Injection Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 13: Europe Water for Injection Market Value (US$ Mn) Forecast, by Solvent, 2017–2031
Table 14: Europe Water for Injection Market Value (US$ Mn) Forecast, by Cleaning Agents, 2017–2031
Table 15: Europe Water for Injection Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 16: Asia Pacific Water for Injection Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Asia Pacific Water for Injection Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 18: Asia Pacific Water for Injection Market Value (US$ Mn) Forecast, by Solvent, 2017–2031
Table 19: Asia Pacific Water for Injection Market Value (US$ Mn) Forecast, by Cleaning Agents, 2017–2031
Table 20: Asia Pacific Water for Injection Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Latin America Water for Injection Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Latin America Water for Injection Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 23: Latin America Water for Injection Market Value (US$ Mn) Forecast, by Solvent, 2017–2031
Table 24: Latin America Water for Injection Market Value (US$ Mn) Forecast, by Cleaning Agents, 2017–2031
Table 25: Latin America Water for Injection Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 26: Middle East & Africa Water for Injection Market Value Forecast, by Country/Sub-region, 2017–2031
Table 27: Middle East and Africa Water for Injection Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 28: Middle East and Africa Water for Injection Market Value (US$ Mn) Forecast, by Solvent, 2017–2031
Table 29: Middle East and Africa Water for Injection Market Value (US$ Mn) Forecast, by Cleaning Agents, 2017–2031
Table 30: Middle East and Africa Water for Injection Market Value (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Water for Injection Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Water for Injection Market Value Share, by Application (2021)
Figure 03: Global Water for Injection Market Value Share, by End-user (2021)
Figure 04: Global Water for Injection Market Value Share, by Region (2021)
Figure 05: Global Water for Injection Market, by Application, 2022 and 2031
Figure 06: Global Water for Injection Market Attractiveness Analysis, by Application, 2022–2031
Figure 07: Global Water for Injection Market Revenue (US$ Mn), by Formulate Parenteral Drugs, 2017–2031
Figure 08: Global Water for Injection Market Revenue (US$ Mn), by Solvent, 2017–2031
Figure 09: Global Water for Injection Market Revenue (US$ Mn), by Cleaning Agents, 2017–2031
Figure 10: Global Water for Injection Market, by End-user 2022 and 2031
Figure 11: Global Water for Injection Market Attractiveness Analysis, by End-user, 2022–2031
Figure 12: Global Water for Injection Market Revenue (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2017–2031
Figure 13: Global Water for Injection Market Revenue (US$ Mn), by Research Institutes, 2017–2031
Figure 14: Global Water for Injection Market Revenue (US$ Mn), by Others, 2017–2031
Figure 15: Global Water for Injection Market, by Region, 2022 and 2031
Figure 16: Global Water for Injection Market Attractiveness Analysis, by Region, 2022–2031
Figure 17: North America Water for Injection Market Value (US$ Mn) Forecast, 2017–2031
Figure 18: North America Water for Injection Market, by Country, 2022 and 2031
Figure 19: North America Water for Injection Market Attractiveness Analysis, by Country, 2022–2031
Figure 20: North America Water for Injection Market, by Application, 2022 and 2031
Figure 21: North America Water for Injection Market Attractiveness Analysis, by Application, 2022–2031
Figure 22: North America Water for Injection Market, by End-user 2022 and 2031
Figure 23: North America Water for Injection Market Attractiveness Analysis, by End-user, 2022–2031
Figure 24: Europe Water for Injection Market Value (US$ Mn) Forecast, 2017–2031
Figure 25: Europe Water for Injection Market, by Country/Sub-region, 2022 and 2031
Figure 26: Europe Water for Injection Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 27: Europe Water for Injection Market, by Application, 2022 and 2031
Figure 28: Europe Water for Injection Market Attractiveness Analysis, by Application, 2022–2031
Figure 29: Europe Water for Injection Market, by End-user 2022 and 2031
Figure 30: Europe Water for Injection Market Attractiveness Analysis, by End-user, 2022–2031
Figure 31: Asia Pacific Water for Injection Market Value (US$ Mn) Forecast, 2017–2031
Figure 32: Asia Pacific Water for Injection Market, by Country/Sub-region, 2022 and 2031
Figure 33: Asia Pacific Water for Injection Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 34: Asia Pacific Water for Injection Market, by Application, 2022 and 2031
Figure 35: Asia Pacific Water for Injection Market Attractiveness Analysis, by Application, 2022–2031
Figure 36: Asia Pacific Water for Injection Market, by End-user 2022 and 2031
Figure 37: Asia Pacific Water for Injection Market Attractiveness Analysis, by End-user, 2022–2031
Figure 38: Latin America Water for Injection Market Value (US$ Mn) Forecast, 2017–2031
Figure 39: Latin America Water for Injection Market, by Country/Sub-region, 2022 and 2031
Figure 40: Latin America Water for Injection Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 41: Latin America Water for Injection Market, by Application, 2022 and 2031
Figure 42: Latin America Water for Injection Market Attractiveness Analysis, by Application, 2022–2031
Figure 43: Latin America Water for Injection Market, by End-user 2022 and 2031
Figure 44: Latin America Water for Injection Market Attractiveness Analysis, by End-user, 2022–2031
Figure 45: Middle East & Africa Water for Injection Market Value (US$ Mn) Forecast, 2017–2031
Figure 46: Middle East & Africa Water for Injection Market, by Country/Sub-region, 2022 and 2031
Figure 47: Middle East & Africa Water for Injection Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 48: Middle East and Africa Water for Injection Market, by Application, 2022 and 2031
Figure 49: Middle East and Africa Water for Injection Market Attractiveness Analysis, by Application, 2022–2031
Figure 50: Middle East and Africa Water for Injection Market, by End-user 2022 and 2031
Figure 51: Middle East and Africa Water for Injection Market Attractiveness Analysis, by End-user, 2022–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Water for Injection Market
*86 figures and 60 tables includes